Аналіз Факторів Дожиття До Замісної Ниркової Терапії Пацієнтів З Хронічною Хворобою Нирок

Kuryata, Olexandr; Frolova, Ye. O.; Yashenko, T.D.

doi:10.22141/2307-1257.7.3.2018.140198

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2) and these findings do not contradict existing concept of CKD progression [3]. In other study of Ukrainian patients with stage 4-5 CKD normal BP was observed only in 10% of patients, LVH -in 90% and more than half of patients had BMI more than 30 kg/m 2 [19]. Interestingly, decline of renal function is associated more strongly with CV risk factors than with AER.…”

Section: Discussionmentioning

confidence: 50%

Analysis of blood pressure control in outpatients with non-dialysis chronic kidney disease referred by primary care physicians: a study from the centre of nephrology care

Kuryata

Yaschenko

Semenov

2019

Arterial Hypertension

View full text Add to dashboard Cite

Background. Patients with chronic kidney disease (CKD) have increased all-cause mortality, especially cardiovascular. The majority of patients with CKD have stages 1-3 and are treated by primary care physicians and nephrologists. Arterial hypertension (HTN) is highly prevalent comorbidity among CKD population, but its control remains poor. Material and methods. This retrospective non-interventional cross-sectional study was conducted in the Centre of Nephrology Care in Dnipropetrovsk Mechnikov Regional Hospital, Dnipro, Ukraine. We aimed to select patients who are supposed to be followed-up by primary care practitioners but due to certain reasons required nephrologist's consultation. From 4540 patients who received medical care in the Centre of Nephrology Care 365 patients fulfilled inclusion criteria. They were subdivided by presence of HTN, CKD stage, presence of proteinuria and achieving blood pressure targets according to different standards. All patients were examined and followed-up according to local and European standards. Results. Forty-nine percent of patients had known HTN, and 21% had HTN de novo. Advance of CKD stage was significantly associated with increase in the most of laboratory findings, age and BP values. Non-proteinuric patients achieved BP goals significantly more often, than proteinuric ones. Females achieved BP targets more often, than males. Monotherapy was the most common treatment regimen. Conclusions. HTN occurs in 70% of patients with CKD and it is controlled in up to 34% of cases. HTN is important factor of CKD progression and it is closely connected with GFR and proteinuria.

show abstract

Section: Discussionmentioning

confidence: 50%